{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:05:21Z","timestamp":1790111121038,"version":"4.0.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/iae.0000000000001048","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T16:14:15Z","timestamp":1461773655000},"page":"2205-2212","source":"Crossref","is-referenced-by-count":24,"title":["BRACHYTHERAPY ALONE OR WITH NEOADJUVANT PHOTODYNAMIC THERAPY FOR AMELANOTIC CHOROIDAL MELANOMA"],"prefix":"10.1097","volume":"36","author":[{"given":"Maria A.","family":"Blasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Laguardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Tagliaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scupola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela G.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Pagliara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210130","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report No. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"R2-22-20210130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/bjo.2009.176198","article-title":"Predicting local control of choroidal melanomas following 106Ru plaque brachytherapy","volume":"95","author":"Papageorgiou","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R3-22-20210130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2005.01.022","article-title":"Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma","volume":"63","author":"Jensen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-22-20210130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","article-title":"The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas","volume":"56","author":"Nag","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-22-20210130","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1118\/1.4749933","article-title":"Dosimetry of (125) I and (103) Pd COMS plaques for intraocular tumors: report of Task Group 129 by AAPM and ABS","volume":"30","author":"Chiu-Tsao","year":"2012","journal-title":"Med Phys"},{"key":"R6-22-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma.","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"R7-22-20210130","first-page":"380","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nature"},{"key":"R8-22-20210130","first-page":"63","article-title":"Photodynamic therapy for the treatment of non-small cell lung cancer","volume":"4","author":"Simone","year":"2012","journal-title":"J Thorac Dis"},{"key":"R9-22-20210130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008390-199510000-00009","article-title":"Photodynamic therapy: a 5-year study of its effectiveness in the treatment of posterior uveal melanoma, and evaluation of haemato-porphyrin uptake and photocytotoxicity of melanoma cells in tissue culture","volume":"5","author":"Favilla","year":"1995","journal-title":"Melanoma Res"},{"key":"R10-22-20210130","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/IAE.10.1097\/IAE.0b013e31822c28ec","article-title":"Treatment of amelanotic choroidal melanoma with photodynamic therapy","volume":"32","author":"Campbell","year":"2012","journal-title":"Retina"},{"key":"R11-22-20210130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1097-0142(1967)20:4<493::AID-CNCR2820200406>3.0.CO;2-U","article-title":"Histogenesis of malignant melanomas of the uvea: II relashionship of uveal nevi to malignant melanomas","volume":"20","author":"Yanoff","year":"1967","journal-title":"Cancer"},{"key":"R13-22-20210130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radial Oncol Biol Phys"},{"key":"R14-22-20210130","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"key":"R15-22-20210130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.radonc.2010.03.023","article-title":"Long-term outcomes of eye-conserving treatment with Ruthenium 106 brachytherapy for choroidal melanoma","volume":"95","author":"Verschueren","year":"2010","journal-title":"Radiother Oncol"},{"key":"R16-22-20210130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000339844","article-title":"Management of radiation maculopathy","volume":"48","author":"Singh","year":"2012","journal-title":"Ophthalmic Res"},{"key":"R17-22-20210130","first-page":"2864","article-title":"Dynamic analyses reveal cytoprotection by RPE melanosomes against non-photic stress","volume":"17","author":"Burke","year":"2011","journal-title":"Mol Vis"},{"key":"R18-22-20210130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1751-1097.2008.00316.x","article-title":"Role of ocular melanin in ophthalmic physiology and pathology","volume":"84","author":"Hu","year":"2008","journal-title":"Photochem Photobiol"},{"key":"R19-22-20210130","first-page":"518","article-title":"Free radical scavenging properties of melanin interaction of eu- and pheo-melanin models with reducing and oxidizing radicals","volume":"26","author":"Rozanowska","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"R20-22-20210130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00347-004-1092-3","article-title":"Photodynamic therapy with verteporfin for uveal melanoma. A clinical histopathological pilot study","volume":"102","author":"Wachtlin","year":"2005","journal-title":"Ophthalmologe"},{"key":"R21-22-20210130","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.12.033","article-title":"Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-Year Outcomes","volume":"117","author":"Blasi","year":"2010","journal-title":"Ophthalmology"},{"key":"R22-22-20210130","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ophtha.2012.01.048","article-title":"Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients","volume":"119","author":"Damato","year":"2012","journal-title":"Ophthalmology"},{"key":"R23-22-20210130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.9-90005-31","article-title":"Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?","volume":"9","author":"Harrison","year":"2004","journal-title":"Oncologist"},{"key":"R24-22-20210130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","article-title":"Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes","volume":"240","author":"Schl\u00f6tzer-Schrehardt","year":"2002","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"key":"R25-22-20210130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/02713689408999883","article-title":"The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative","volume":"13","author":"Lin","year":"1994","journal-title":"Curr Eye Res"},{"key":"R27-22-20210130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000209670","article-title":"Blood vessel maturation in human uveal melanoma: spatial distribution of neovessels and mature vasculature","volume":"41","author":"Pi\u00f1a","year":"2009","journal-title":"Ophthalmic Res"},{"key":"R28-22-20210130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0002-9440(10)63809-6","article-title":"Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy","volume":"162","author":"Gee","year":"2003","journal-title":"Am J Pathol"},{"key":"R29-22-20210130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2004.08.008","article-title":"Targeting the tumor vascular compartment to improve conventional cancer therapy","volume":"25","author":"Feron","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"R30-22-20210130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20091846","article-title":"Resistence to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization and maturation in malignant melanoma","volume":"207","author":"Helfrich","year":"2010","journal-title":"J Exp Med"},{"key":"R31-22-20210130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years COMS report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"key":"R32-22-20210130","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.118.9.1219","article-title":"Plaque radiotherapy for uveal melanoma. Long-term visual outcome in 1106 consecutive patients","volume":"118","author":"Shields","year":"2000","journal-title":"Arch Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000001048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:15:31Z","timestamp":1620954931000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201611000-00022"}},"subtitle":["Functional Outcomes and Local Tumor Control"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001048","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}